Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online

High-quality, well-validated reagents for infectious diseases

Discover our wide range of high-quality, well-validated proteomic reagents with excellent batch-to-batch consistency and guaranteed long-term supply to help accelerate your next breakthrough in infectious disease research and drug discovery.  

Browse all infectious disease products

Published February 10, 2022

Contents

Infectious diseases at Abcam

As we have seen during the COVID-19 pandemic, new pathogens and new variants of existing pathogens can emerge rapidly. Finding high-quality specific reagents for emerging pathogens is one of the major challenges faced by scientists studying infectious diseases. When a new viral outbreak or new variants of an existing pathogen appear, researchers need to quickly find the right tools to study it. However, many reagents on the market have poor quality and are not specific to the strain of interest. 

At Abcam, we have a passion for infectious diseases and are relentless in our focus to provide reliable and consistent reagents to support your research, drug discovery and diagnostics. We offer you the tools required today, from recombinant antibodies to high-throughput assays, and continuously anticipate your future needs. 

Helping you make a breakthrough in infectious diseases

To provide you with tools you need to study pathogens and host immune responses in infectious diseases, we offer a comprehensive proteomics portfolio of antibodies, ELISA kits, proteins and cell lines for existing and new targets in:

  • common respiratory infections, such as influenza, respiratory syncytial virus (RSV) infection and pneumonia, as well as SARS-CoV-2.

To anticipate your future needs, we continually update our product portfolio, identifying and prioritizing the most relevant targets. We are also producing products for pathogens that WHO deems to be of high pandemic potential and are committed to generating reagents for every target in the SARS-CoV-2 virus.

If a research tool you need is not available off the shelf, our in-house team of experts will work with you to create a customized solution.

Our end-to-end portfolio in infectious diseases

Explore our expansive portfolio to find high-quality products for your pathogen, target or disease of interest, or browse our recommended products for influenza, HIV, and hepatitis B research in the sections below.

Choose from three main groups of reagents for infectious disease research:


Recombinant monoclonal antibodies


ELISA kits


​

Recombinant proteins

Detect and characterize pathogens of interest in various sample types

Characterize immune response towards a particular pathogen/variant 

Develop new assays or use them as controls

  • Overcome reproducibility and supply issues with recombinant monoclonal antibodies for specific pathogen strains/genotypes of interest.
  • Superior batch-to-batch consistency, uninterrupted supply, and unrivaled specificity
  • Validated for key applications, including immunofluorescence/ICC, IHC, western blot, ELISA

  • A wide range of specific and sensitive serology assays that allow you to detect antibodies against your pathogen of interest


  • Native antigens for developing immunodiagnostic tests (closely resemble the antigen in clinical samples).



Antibodies and proteins to support influenza research

Advance your influenza research with our high-quality antibodies and proteins targeting influenza A and B viruses (Fig. 1), including common strains such as H1N1 and H5N1. Find below reagents for key influenza virus segments: nucleoproteins, hemagglutinins, matrix protein M1, ion-channel M2, non-structural proteins NS1 and NS2, and viral polymerase subunits (PB1, PB2, and PA).  

Figure 1. Schematic representation of influenza virus structure. Adapted from Dou D, et al. Front Immunol. 2018. 

Click on the targets below to explore our wide range of products.

Influenza A virus nucleoprotein | Influenza A virus | Influenza A virus Hemagglutinin | Influenza B virus Nucleoprotein | Influenza A virus M2 protein

Antibodies and proteins to support HIV research

Achieve reproducible results in HIV research, with our wide range of recombinantly produced antibodies and proteins to key HIV structural and regulatory proteins, including group-specific antigen (gag), envelope glycoprotein (env), reverse transcriptase (pol) (Fig. 2). 

Figure 2. Schematic representation of HIV1 virus and its three major proteins gag, env, pol.

Click on the targets below to explore our wide range of products.

Gag structural proteins: HIV1 p24 | HIV1 p17 | HIV1 p55+p24+p17 | HIV1 p55+ p17 | HIV1 p15 | HIV1 p55

Env structural proteins: HIV1 gp120 | HIV1 gp41 | HIV gp160 | HIV2 gp36 | HIV1 +HIV2 envelope antigen | HIV1 gp120+gp41

Pol structural proteins: HIV1 reverse transcriptase | HIV1 integrase | HIV1 protease

Regulatory proteins: HIV1 nef | HIV1 tat | HIV1 vif 

Antibodies and proteins to support hepatitis B research

Accelerate your hepatitis B research with our high-quality recombinant antibodies and proteins to the key targets, including core antigen, antigen X, surface antigen, and antigen E (Fig. 3). 

Figure 3. Schematic representation of hepatitis B virus.

Click on the targets below to explore our wide range of products. 

Core Antigen | Antigen X antibodies  | Protein X | Surface Antigen | Antigen E protein